The homeostasis of the human body works like a machine set at a particular standard. If the factors deviate from the standard values, the homeostatic mechanism come into action.
For example, if a cell requires certain protein, the respective genes get a signal and get activated. The cell start synthesizing the protein and when sufficient amount is made, there is a feedback loop, which allows the same protein to stop the synthesis as well. A lot of organs and cellular systems are involved in regulating the synthesis of this protein.
This is similar to the cooling system. If we set the temperature of the cooling system to certain degree, it will start cooling the room till the required temperature is reached. As soon as the temperature is acquired, the system cut-off automatically and the required temperature is maintained.
The nucleus is an organelle found in eukaryotic cells. Inside its fully enclosed nuclear membrane, it contains the majority of the cell's genetic material. This material is organized as DNA molecules, along with a variety of proteins, to form chromosomes.
Germination I think that it’s
Umm well from my studies shown that its extintion
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
